title: Editorial commentary: how can understanding the phenotype of Pseudomonas aeruginosa lead to more successful eradication strategies in cystic fibrosis?
authors.affiliation: Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
authors.forename: Valerie
authors.initials: V
authors.lastname: Waters
mesh_terms: D001249:Asthma / Q000150:complications*; D003550:Cystic Fibrosis / Q000382:microbiology*; D005260:Female; D006801:Humans; D008297:Male; D011008:Pneumococcal Infections / Q000453:epidemiology*; D022242:Pneumococcal Vaccines; D011018:Pneumonia, Pneumococcal / Q000453:epidemiology*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology* / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000166:cytology* / Q000502:physiology*
chemical_list: D022242:Pneumococcal Vaccines
keywords: Pseudomonas; cystic fibrosis; eradication